Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7814512 | 0.94 | KMT2A (0.39) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL2156525 | 0.89 | CYP2D6 (0.42) | KMT2ASMN1; SMN2STAT3CYP3A4CYP2C9 | |
| SCHEMBL17824227 | 0.88 | CYP3A4 (0.43) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL10015859 | 0.88 | KMT2A (0.39) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL3698657 | 0.87 | CA12 (0.42) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL690833 | 0.85 | STAT3 (0.40) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL16641783 | 0.85 | KMT2A (0.49) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL19106783 | 0.84 | CA12 (0.41) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL10171744 | 0.84 | CYP3A4 (0.48) | KMT2ASMN1; SMN2STAT3GAACA12 | |
| SCHEMBL20898576 | 0.83 | STAT3 (0.41) | KMT2ASMN1; SMN2STAT3GAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 342 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114075155-B | Bisphenol A derivative, preparation method thereof and application thereof in lithography | 中国科学院化学研究所 | 2023-08-01 | — | — | CN | claimed |
| US-20220373885-A1 | BISPHENOL A DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN PHOTOLITHOGRAPHY | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2022-11-24 | — | — | US | claimed |
| CN-114075155-A | Bisphenol A derivative, preparation method thereof and application thereof in photoetching | 中国科学院化学研究所 | 2022-02-22 | — | — | CN | claimed |
| EP-4251620-B1 | AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS | CHIESI FARM SPA (IT) | 2025-04-16 | — | — | EP | disclosed |
| EP-4536356-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | Xenon Pharmaceuticals Inc. (CA) | 2025-04-16 | — | — | EP | disclosed |
| EP-4522618-A1 | TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES COMPOUNDS AS HPK1 INHIBITORS | Merck Patent GmbH (DE) | 2025-03-19 | — | — | EP | disclosed |
| US-20240174656-A1 | FUSED RING AROMATIC HYDROCARBON DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN LITHOGRAPHY | INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2024-05-30 | — | — | US | disclosed |
| CN-118047739-A | Polycyclic aromatic hydrocarbon derivative, preparation method thereof and application thereof in photoetching | 中国科学院化学研究所 | 2024-05-17 | — | — | CN | disclosed |
| US-20240101531-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | XENON PHARMACEUTICALS INC. (CA) | 2024-03-28 | — | — | US | disclosed |
| US-20240093027-A1 | POLYMERS USEFUL AS SURFACE LEVELING AGENTS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-03-21 | — | — | US | disclosed |
| US-20240025922-A1 | TETRAHYDROPYRIDO[3,4-d]PYRIMIDINES AS HPK1 INHIBITORS | MERCK HEALTHCARE KGAA (DE) | 2024-01-25 | — | — | US | disclosed |
| US-5663289-A | BINDERS | AEROJET-GENERAL CORPORATION (US) | 1997-09-02 | — | — | US | disclosed |
| US-5654450-A | THERMOPLASTIC RESIN INTERMEDIATES; TEAR STRENGTH, ADHESION | AEROJET-GENERAL CORPORATION (US) | 1997-08-05 | — | — | US | disclosed |
| US-5650483-A | PREPARING A SOLUTION OF A CATALYST, AN INITIATOR AND A SOLVENT, CONTACTING SOLUTION WITH A SECOND SOLUTION CONTAINING FLUORINATED OXETANE MONOMER(S) AND CONTROLLING THE TEMPERATURE OF THE MIXTURE | AEROJET-GENERAL CORPORATION (US) | 1997-07-22 | — | — | US | disclosed |
| US-5637772-A | OIL REPELLENT COATINGS; ANTIFOULING AGENTS; RELEASE AGENTS; ENCAPSULATION OF ELECTRICAL DEVICES; CURING AGENT FOR EPOXIDES | AEROJET GENERAL CORPORATION (US) | 1997-06-10 | — | — | US | disclosed |
| WO-1996021657-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1996-07-18 | — | — | WO | disclosed |
| US-5362848-A | Preparation and polymerization of initiators containing multiple oxetane rings: new routes to star polymers | AEROJET-GENERAL CORPORATION (US) | 1994-11-08 | — | — | US | disclosed |
| US-4865641-A | Herbicidal new thiazolyl ether and thioether derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1989-09-12 | — | — | US | disclosed |
| EP-0281907-A1 | Thiazolyl ether and thioether derivatives | BAYER AG (DE) | 1988-09-14 | — | — | EP | disclosed |
| EP-0273242-A2 | 2-Pyri(mi)dylthio-aryl ether | BAYER AG (DE) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220373885-A1 | BISPHENOL A DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN PHOTOLITHOGRAPHY | WASF2, BCL2L11, PCNA | KMT2A 1796/4885SMN1; SMN2 4860/4885STAT3 3132/4885 |
| US-20240174656-A1 | FUSED RING AROMATIC HYDROCARBON DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN LITHOGRAPHY | WASF2, FZD7, TCF7L2 | KMT2A 1823/4885SMN1; SMN2 4885/4885STAT3 4026/4885 |
| US-20240101531-A1 | PYRIDINAMINE DERIVATIVES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS | KCNA1, KCNB1, KCNB2 | KMT2A 692/4885SMN1; SMN2 1030/4885STAT3 4550/4885 |
| US-20240025922-A1 | TETRAHYDROPYRIDO[3,4-d]PYRIMIDINES AS HPK1 INHIBITORS | PDXK, DTYMK, HIPK1 | KMT2A 2685/4885SMN1; SMN2 3927/4885STAT3 3714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.